Final 5‐year results of Z‐FAST trial von Brufsky, Adam M., Harker, W. Graydon, Beck, J. Thaddeus, Bosserman, Linda, Vogel, Charles, Seidler, Christopher, Jin, Lixian, Warsi, Ghulam, Argonza‐Aviles, Eliza, Hohneker, John, Ericson, Solveig G., Perez, Edith A.

Volltext

Final 5-Year Results of Z-FAST Trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole von BRUFSKY, Adam M, GRAYDON HARKER, W, ERICSON, Solveig G, PEREZ, Edith A, THADDEUS BECK, J, BOSSERMAN, Linda, VOGEL, Charles, SEIDLER, Christopher, LIXIAN JIN, WARSI, Ghulam, ARGONZA-AVILES, Eliza, HOHNEKER, John

Volltext

Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study von Raje, Noopur, Vescio, Robert, Montgomery, Charles W, Badros, Ashraf, Munshi, Nikhil, Orlowski, Richard, Hadala, Joseph T, Warsi, Ghulam, Argonza-Aviles, Eliza, Ericson, Solveig G, Anderson, Kenneth C

Volltext

Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung can... von Pandya, Kishan J, Gajra, Ajeet, Warsi, Ghulam M, Argonza-Aviles, Eliza, Ericson, Solveig G, Wozniak, Antoinette J

Volltext

Bone Marker Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Primary Analysis Results of the Z-MARK Study von Raje, Noopur, Vescio, Robert, Montgomery, Charles W., Parameswaran, Ramakrishnan, Tran, Diep, Warsi, Ghulam, Argonza-Aviles, Eliza, Ericson, Solveig G., Anderson, Kenneth C.

Volltext

Bone Marker Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications In Patients with Multiple Myeloma: Interim Analysis Results of the Z-MARK Study von Raje, Noopur, Vescio, Robert, Montgomery, Charles W., Parameswaran, Ramakrishnan, Tran, Diep, Warsi, Ghulam, Argonza-Aviles, Eliza, Ericson, Solveig G., Anderson, Kenneth C.

Volltext